Michael is a PhD Candidate in the Department of Systems Pharmacology and Translational Therapeutics at Perelman. He developed CAR-macrophages for his doctoral thesis under the co-mentorship of Saar Gill, MD, PhD and Carl June, MD. Michael previously earned a Doctor of Pharmacy degree from the University of Sciences in Philadelphia.  Michael’s scientific expertise is in the field of genetic engineering and immunology, with a focus on chimeric antigen receptor technologies. Michael's talk will focus on his work in Carl June's lab as well as his work as an innovator and company founder while being a graduate student at Penn. Michael co-founded CARMA therapeutics, which you can read more about here https://carmatherapeutics.com/.